-
1.
公开(公告)号:US20120129897A1
公开(公告)日:2012-05-24
申请号:US13297386
申请日:2011-11-16
申请人: Joseph Kent Barbay , Kristi Anne Leonard , Yan Zhang , Brett Andrew Tounge , Aihua Wang , Michael Hawkins , Paul Francis Jackson , Umar S.M. Maharoof
发明人: Joseph Kent Barbay , Kristi Anne Leonard , Yan Zhang , Brett Andrew Tounge , Aihua Wang , Michael Hawkins , Paul Francis Jackson , Umar S.M. Maharoof
IPC分类号: A61K31/427 , A61P35/00 , A61P19/02 , A61P19/08 , A61P9/00 , A61P1/04 , A61P9/12 , A61P11/00 , A61P29/00 , A61P1/00 , A61P1/02 , A61P17/02 , A61P1/16 , A61P25/00 , A61P11/06 , A61P25/06 , A61P9/10 , C07D417/04
CPC分类号: C07D417/04
摘要: This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables A, Q, J, R1, R3, and R5 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.
摘要翻译: 本发明涉及噻唑I及其治疗和预防用途,其中变量A,Q,J,R 1,R 3和R 5在本说明书中定义。 治疗和/或预防的疾病包括类风湿性关节炎。
-
2.FUSED HETEROARYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION 审中-公开
标题翻译: 熔融金属蛋白酶激活的融合异氟醚抑制剂公开(公告)号:US20120129872A1
公开(公告)日:2012-05-24
申请号:US13297395
申请日:2011-11-16
申请人: Kristi Anne Leonard , Yan Zhang , Brett Andrew Tounge , Aihua Wang , Michael Hawkins , Paul Francis Jackson , Joseph Kent Barbay , Umar S.M. Maharoof
发明人: Kristi Anne Leonard , Yan Zhang , Brett Andrew Tounge , Aihua Wang , Michael Hawkins , Paul Francis Jackson , Joseph Kent Barbay , Umar S.M. Maharoof
IPC分类号: A61K31/496 , C07D417/04 , C07D471/04 , C07D417/14 , A61K31/427 , A61K31/437 , A61P35/00 , A61P19/02 , A61P19/08 , A61P9/00 , A61P1/04 , A61P9/12 , A61P11/00 , A61P29/00 , A61P1/00 , A61P17/02 , A61P25/00 , A61P11/06 , A61P25/06 , A61P13/12 , A61P9/10 , C07D417/10
CPC分类号: C07D417/12 , C07D417/14 , C07D471/04
摘要: This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables A, Q, J, R1, R3, and R5 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.
摘要翻译: 本发明涉及噻唑I及其治疗和预防用途,其中变量A,Q,J,R 1,R 3和R 5在本说明书中定义。 治疗和/或预防的疾病包括类风湿性关节炎。
-
3.
公开(公告)号:US20120129843A1
公开(公告)日:2012-05-24
申请号:US13297412
申请日:2011-11-16
申请人: Yan ZHANG , Brett Andrew Tounge , Aihua Wang , Michael Hawkins , Kristi Anne Leonard , Joseph Kent Barbay , Umar S.M. Maharoof
发明人: Yan ZHANG , Brett Andrew Tounge , Aihua Wang , Michael Hawkins , Kristi Anne Leonard , Joseph Kent Barbay , Umar S.M. Maharoof
IPC分类号: A61K31/4439 , C07D417/14 , A61K31/496 , A61K31/5377 , A61K31/551 , A61P35/00 , A61P19/02 , A61P29/00 , A61P9/00 , A61P1/04 , A61P9/12 , A61P11/00 , A61P1/00 , A61P1/02 , A61P17/02 , A61P1/16 , A61P19/04 , A61P25/00 , A61P11/06 , A61P13/12 , A61P25/06 , A61P9/10 , C07D417/04
CPC分类号: C07D417/04
摘要: This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables Rz, Q, J, R1, R3, R5, and R6 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.
摘要翻译: 本发明涉及噻唑I及其治疗和预防用途,其中变量Rz,Q,J,R1,R3,R5和R6在本说明书中定义。 治疗和/或预防的疾病包括类风湿性关节炎。
-
4.BISTHIAZOLE INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION 审中-公开
标题翻译: PRO-MATRIX金属蛋白酶激活的双嘧达莫抑制剂公开(公告)号:US20120129842A1
公开(公告)日:2012-05-24
申请号:US13297400
申请日:2011-11-16
申请人: Paul Francis JACKSON , Brett Andrew Tounge , Kristi Anne Leonard , Yan Zhang , Aihua Wang , Michael Hawkins , Umar S.M. Maharoof , Joseph Kent Barbay
发明人: Paul Francis JACKSON , Brett Andrew Tounge , Kristi Anne Leonard , Yan Zhang , Aihua Wang , Michael Hawkins , Umar S.M. Maharoof , Joseph Kent Barbay
IPC分类号: A61K31/551 , C07D417/14 , A61K31/427 , A61K31/454 , A61K31/496 , A61K31/4709 , A61K31/5377 , A61P35/00 , A61P19/02 , A61P19/08 , A61P9/00 , A61P1/04 , A61P9/12 , A61P11/00 , A61P1/00 , A61P29/00 , A61P17/02 , A61P1/16 , A61P25/00 , A61P11/06 , A61P13/12 , A61P25/06 , A61P9/10 , C07D417/04
CPC分类号: C07D277/42 , C07D417/12 , C07D417/14
摘要: This invention relates to bisthiazole I and its therapeutic and prophylactic uses, wherein the variables A, R5, R6, and R7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.
摘要翻译: 本发明涉及双噻唑I及其治疗和预防用途,其中变量A,R5,R6和R7在本说明书中定义。 治疗和/或预防的疾病包括类风湿性关节炎。
-
5.TRICYCLIC INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION 审中-公开
标题翻译: PRO-MATRIX金属蛋白酶激活的三嵌段抑制剂公开(公告)号:US20120129811A1
公开(公告)日:2012-05-24
申请号:US13297421
申请日:2011-11-16
申请人: Aihua WANG , Yan Zhang , Kristi Anne Leonard , Michael Hawkins , Brett Andrew Tounge , Umar S.M. Maharoof , Joseph Kent Barbay
发明人: Aihua WANG , Yan Zhang , Kristi Anne Leonard , Michael Hawkins , Brett Andrew Tounge , Umar S.M. Maharoof , Joseph Kent Barbay
IPC分类号: A61K31/429 , C07F9/6561 , A61K31/496 , A61K31/675 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61K31/437 , A61P35/00 , A61P19/02 , A61P19/08 , A61P9/00 , A61P1/04 , A61P9/12 , A61P11/00 , A61P1/00 , A61P29/00 , A61P1/02 , A61P17/02 , A61P1/16 , A61P25/00 , A61P11/06 , A61P13/12 , A61P25/06 , A61P9/10 , C07D513/04
CPC分类号: C07D513/06
摘要: This invention relates to tricycle I and its therapeutic and prophylactic uses, wherein the variables C1, C2, Z1, Z2, Q, J, R1, and R3 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.
摘要翻译: 本发明涉及三轮车I及其治疗和预防用途,其中变量C1,C2,Z1,Z2,Q,J,R1和R3在本说明书中定义。 治疗和/或预防的疾病包括类风湿性关节炎。
-
6.PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION 审中-公开
标题翻译: PRO-MATRIX金属蛋白酶激活的苯基 - 噻唑啉酮抑制剂公开(公告)号:US20120302569A1
公开(公告)日:2012-11-29
申请号:US13479395
申请日:2012-05-24
申请人: Paul Francis JACKSON , Kristi Anne Leonard , Joseph Kent Barbay , Aihua Wang , Brett Andrew Tounge , Yan Zhang , Umar S.M. Maharoof
发明人: Paul Francis JACKSON , Kristi Anne Leonard , Joseph Kent Barbay , Aihua Wang , Brett Andrew Tounge , Yan Zhang , Umar S.M. Maharoof
IPC分类号: A61K31/427 , A61K31/496 , A61K31/4439 , C07D417/14 , A61K31/444 , A61K31/454 , C07D417/12 , A61K31/5377 , A61P35/00 , A61P19/02 , A61P29/00 , A61P9/00 , A61P1/04 , A61P9/12 , A61P11/00 , A61P1/00 , A61P1/02 , A61P17/02 , A61P1/16 , A61P25/00 , A61P11/06 , A61P13/12 , A61P25/06 , A61P9/10 , C07D417/10
CPC分类号: C07D417/12 , C07D277/42 , C07D417/14
摘要: This invention relates to phenyl thiazole I and its therapeutic and prophylactic uses, wherein the variables Rz, Q, J, R1, R3, R5, R6, and R7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.
摘要翻译: 本发明涉及苯基噻唑I及其治疗和预防用途,其中变量Rz,Q,J,R1,R3,R5,R6和R7在本说明书中定义。 治疗和/或预防的疾病包括类风湿性关节炎。
-
-
-
-
-